A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

This study has been completed.
Sponsor:
Collaborators:
Gachon University Gil Medical Center
The Catholic University of Korea
Kyungpook National University
Daegu Catholic University Medical Center
Wonkwang University Hospital
Wonju Severance Christian Hospital
Korea University Guro Hospital
DongGuk University
Yeungnam University
Chonnam National University Hospital
Cheil General Hospital and Women’s Healthcare Center
Chungnam National University
Asan Medical Center
Seoul National University Bundang Hospital
Inha University Hospital
Seoul National University Hospital
Inje University
Samsung Medical Center
Busan National University Yangsan Hospital
Soon Chun Hyang University
Catholic University of Korea Saint Paul's Hospital
Hallym University Kangnam Sacred Heart Hospital
Jeju National University Hospital
Hanyang University Seoul Hospital
Kangbuk Samsung Hospital
Information provided by (Responsible Party):
Boryung Pharmaceutical Co., Ltd
ClinicalTrials.gov Identifier:
NCT01518998
First received: January 24, 2012
Last updated: June 29, 2016
Last verified: June 2016